Noninvasive Assessment of Neuromuscular Disease Using Electrical Impedance Myography
- Conditions
- Amyotrophic Lateral Sclerosis (ALS)
- Interventions
- Device: EIM Measurements
- Registration Number
- NCT01803386
- Lead Sponsor
- Skulpt, Inc.
- Brief Summary
The purpose of this protocol is to test a new Electrical Impedance Myography (EIM) device and study its reliability and ability to differentiate ALS patients from healthy controls.
- Detailed Description
Investigators will study 10 ALS patients and at least 10 age-matched healthy controls between the ages of 21 and 85 years old. For all subjects, EIM measurements will be performed on four muscles: two in the upper and two in the lower extremities, using 8 different EIM sensors. Measurements will be repeated one time.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 20
- Diagnosis of probable or definite ALS by the El Escorial Criteria
- History of superimposed generalized neuromuscular disease
- Primary lateral sclerosis or other atypical motor neuron disorders
- Forced vital capacity of less than 50%
- Presence of disease for greater than 5 years since symptom onset
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description ALS Subjects EIM Measurements EIM measurements will be taken on two upper and two lower extremity muscles with several different electrode arrays. The ALSFRS-R will also be administered. Subcutaneous fat measurement will also be performed on all four muscles using skinfold calipers. Healthy Subjects EIM Measurements EIM measurements will be taken on two upper and two lower extremity muscles with several different electrode arrays. Subcutaneous fat measurement will also be performed on all four muscles using skinfold calipers.
- Primary Outcome Measures
Name Time Method Muscle health as captured by EIM measurements One time visit - Day 1 EIM measurements will be performed with several electrode arrays at one visit per patient. The data captured from ALS and healthy subjects will be used to refine and finalize electrode array design development for the EIM system.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Convergence Medical Devices
🇺🇸Boston, Massachusetts, United States